Poster and oral presentation (presented by Caroline Schröder) at the 5th International Inflammatory Breast Cancer Conference in Boston (MA, USA) on July 10th 2016.
Related posts
Quantitative proteomics analysis identifies MUC1 as an effect sensor of EGFR inhibition
TPX2/Aurora kinase A signaling as a potential therapeutic target in genomically unstable cancer cells
